Stay updated with breaking news from 46433010. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lisanti Capital Growth LLC purchased a new stake in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 62,415 shares of the company’s stock, valued at approximately $3,158,000. Several other large investors also recently […]
Lisanti Capital Growth LLC purchased a new stake in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 62,415 shares of the company’s stock, valued at approximately $3,158,000. Other institutional investors and hedge funds […]
Ionis Pharmaceuticals (NASDAQ:IONS – Get Free Report) issued its earnings results on Wednesday. The company reported ($0.06) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.78) by $0.72, MarketWatch Earnings reports. The company had revenue of $325.00 million during the quarter, compared to analysts’ expectations of $176.01 million. Ionis Pharmaceuticals had […]
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) shares gapped up before the market opened on Wednesday after the company announced better than expected quarterly earnings. The stock had previously closed at $44.35, but opened at $45.92. Ionis Pharmaceuticals shares last traded at $44.95, with a volume of 147,330 shares. The company reported ($0.06) earnings […]
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) gapped up before the market opened on Wednesday following a better than expected earnings announcement. The stock had previously closed at $44.35, but opened at $45.92. Ionis Pharmaceuticals shares last traded at $44.95, with a volume of 147,330 shares changing hands. The company reported ($0.06) earnings per […]